Arseniy P Yashkin
Overview
Explore the profile of Arseniy P Yashkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yashin A, Wu D, Arbeev K, Yashkin A, Akushevich I, Bagley O, et al.
J Transl Genet Genom
. 2021 Nov;
5(4):357-379.
PMID: 34825130
Aim: Experimental studies provided numerous evidence that caloric/dietary restriction may improve health and increase the lifespan of laboratory animals, and that the interplay among molecules that sense cellular stress signals...
12.
Yu B, Akushevich I, Yashkin A, Kravchenko J
Front Cardiovasc Med
. 2021 Sep;
8:707102.
PMID: 34568451
There are substantial geographic disparities in the life expectancy (LE) across the U.S. with myocardial infarction (MI) contributing significantly to the differences between the states with highest (leading) and lowest...
13.
Ukraintseva S, Duan M, Arbeev K, Wu D, Bagley O, Yashkin A, et al.
Front Cell Dev Biol
. 2021 Sep;
9():692020.
PMID: 34490245
A major goal of aging research is identifying genetic targets that could be used to slow or reverse aging - changes in the body and extend limits of human lifespan....
14.
Akushevich I, Yashkin A, Kravchenko J, Yashin A
J Alzheimers Dis
. 2021 Jun;
82(3):1277-1289.
PMID: 34151800
Background: Understanding the dynamics of epidemiologic trends in Alzheimer's disease (AD) and related dementias (ADRD) and their epidemiologic causes is vital to providing important insights into reducing the burden associated...
15.
Akushevich I, Yashkin A, Yashin A, Kravchenko J
J Am Geriatr Soc
. 2021 May;
69(8):2306-2315.
PMID: 34009643
Objectives: The regions with highest and lowest Alzheimer's disease (AD) mortality across the United States at state/county levels were identified and their contribution to the differences in total mortality rates...
16.
Akushevich I, Yashkin A, Kravchenko J, Kertai M
JCO Oncol Pract
. 2021 Feb;
17(11):e1649-e1659.
PMID: 33630665
Purpose: Evidence on the nature of the relationship between patients receiving chemotherapy as an essential part of guideline-concordant cancer care and the onset of Alzheimer's Disease (AD) and other adverse...
17.
Akushevich I, Yashkin A, Greenup R, Hwang E
NPJ Breast Cancer
. 2020 Nov;
6:57.
PMID: 33145400
Over 97% of individuals diagnosed with ductal carcinoma in situ (DCIS) will choose to receive guideline concordant care (GCC), which was originally designed to treat invasive cancers and is associated...
18.
Akushevich I, Yashkin A, Inman B, Sloan F
Ann Epidemiol
. 2020 Jul;
47:25-29.
PMID: 32713504
Purpose: The aim of the study was to evaluate the relative contributions of incidence, stage-specific relative survival, and stage ascertainment to changes in bladder cancer (BC) prevalence and incidence-based mortality....
19.
Yashkin A, Greenup R, Gorbunova G, Akushevich I, Oeffinger K, Hwang E
JCO Oncol Pract
. 2020 Jul;
17(4):e469-e478.
PMID: 32692618
Purpose: Increasing health care costs, longer life expectancy, improved breast cancer (BC) survival, and higher levels of complex comorbidities have important implications for future Medicare expenditures. Methods: Data from the...
20.
Sloan F, Yashkin A, Akushevich I, Inman B
Urol Oncol
. 2019 Nov;
38(2):39.e11-39.e19.
PMID: 31761612
Background: Bladder cancer (BC) is highly prevalent and costly. This study documented cost and use of services for BC care and for other (non-BC) care received over a 15-year follow-up...